Original news and analysis on international IP policy
A recent paper published by the Max Planck Institute for Innovation and Competition criticises a joint study by the European patent and trademark offices as lacking insight about the economic effects of intellectual property.
Universities Allied for Essential Medicines is calling for new incentive models for research and development so that new treatments can be found for neglected tropical diseases to fight antibiotic resistance, and is asking that health issues supersede trade interests.
A new legal analysis looks at the 1 July oral hearing of the European Court of Justice (CJEU) on Spain’s nullity actions against the regulations on the “unitary patent” and its language regime.
Compulsory licences should be issued to roll out generic versions of innovative HCV drugs. Only generic competition can push down the extortionate prices of these lifesaving medicines, while placing equitable access and public interest before monopolistic pharma companies’ business strategies, Daniele Dionisio argues.
A new United Kingdom copyright exception for private copying cleared Parliament on 29 July and will become law in October. The change brought cheers from high-tech and digital rights groups. UK Music, however, said the new regulation will hurt creators and that it is considering legal action.
The Polish Parliament is currently finalising work on a bill designed to make using anti-plagiarism software compulsory for Polish higher education institutions (HEIs). With the new law, universities are to become obliged to check all Bachelor’s, Master’s and Ph.D. theses to detect acts of plagiarism. However, local observers doubt whether the bill will provide Polish HEIs with sufficient means to counter this widespread problem and protect intellectual property.
With an increase in the number of entrepreneur artisans in Uganda, a need to protect and benefit from the artisan works has emerged in the country. There is a growing trend in rights management, especially in the fields of musical works, film and art.
The International Centre for Trade and Sustainable Development recently issued papers on competition analyses of licensing agreements and on the measurement of trade and innovation.
The Medicines Patent Pool today announced a new licensing agreement with Gilead Sciences for a new treatment still undergoing clinical trials. This agreement is expected to allow Chinese and Indian generic manufacturers to provide low-cost versions of the drug in 112 low-and middle-income countries.
Microsoft, a strong advocate of intellectual property protection, has launched an online IP portal in Kenya with the aim of helping innovators better understand different means of protecting their software and reap the economic benefits of their innovations. The initiative is planned to spread to other African countries.
A European Union-funded initiative is seeking to strengthen the links between small and medium-sized enterprises (SMEs) and the research community on environmental technologies.
The Medicines Patent Pool has announced seven new sub-licensing agreements to produce generic HIV medicines in order to make more affordable versions available to developing countries.